Masonic Cancer Center Research Symposium

The Masonic Cancer Center, University of Minnesota is hosting its 11th Annual Cancer Research Symposium on October 30, 2023. This symposium is for Masonic Cancer Center faculty, staff, trainees, and students to celebrate research accomplishments and to develop new ideas and collaborations.
There is no fee* to attend, but registration is required. The deadline to register is Friday, October 20, 2023.
*Industry Representatives and any attendee external to the Masonic Cancer Center who are interested in attending will register separately—please use this link.
Questions? Contact the event organizers at mccevents@umn.edu or 612-624-7552.

Electra Paskett
Keynote speaker
Electra D. Paskett, PhD, became the Marion N. Rowley Professor of Cancer Research at The Ohio State University in 2002. She is the Director of the Division of Cancer Prevention and Control in the College of Medicine, a professor in the Division of Epidemiology in the College of Public Health, and the Associate Director for Population Sciences and Program Leader of the Cancer Control Program in the Comprehensive Cancer Center of the Ohio State University (OSU). She is also Director of the Center for Cancer Health Equity at the James Cancer Hospital. Dr. Paskett’s research program is nationally recognized for studying cancer health disparities utilizing a "team science approach."
Symposium Agenda
10,000 Families Cohort for Environmental Exposure and Cancer Risk
Integrated Immune Engineering for Poor Prognosis Cancer
Branden Moriarity, PhD
Department of Pediatrics
Collaborative Approaches for Tackling Diverse Phenotypes of Advanced Prostate Cancer
Abstract Competition and Poster Session
Students, staff, and postdocs are encouraged to participate and submit an abstract for the poster sessions. *Note that you must be available to present your poster on the day of the event. You will have the option of presenting in the morning or afternoon. You will be asked to select your preferred presentation window in the submission process.
Abstract submissions are due by Monday, September 11 at 11:59 pm.
Announcements on selected abstracts will be made at the beginning of October.
Top Abstracts
The top three outstanding abstracts will be selected to present a talk at the Symposium and each will receive a $1,500 travel award.
In addition to participating in the poster session, the top 10 abstract winners will be selected to attend lunch with the keynote speakers.
Poster Guidelines
A title page with presenter, mentor, and research program listed, as well as a keywords page with authors and a link to the electronic abstract will be provided by the Masonic Cancer Center at your poster site.
In addition to these two provided sheets, you should use up to four 8 ½ x 11 pages to create your poster. We recommend using an easily readable font size and landscape orientation. Suggested information layout is to have a Hypothesis and Approach page, two Data pages, and one Conclusions and Next Steps page.
You will need to print your four pages and bring them to the Symposium. The title page and key words page will be provided at your poster site. Detailed information regarding your poster location, set up timing, etc. will be emailed to you in October.
Exhibitor & Sponsor Opportunities
The mission of the Masonic Cancer Center’s Annual Cancer Research Symposium is to engage our 500+ members including faculty, researchers, trainees, and students in celebration of research accomplishments and to create a motivational event to spur new ideas and collaborations towards developing new research.
Industry partners are crucial collaborators to scientific progress and are invited to participate as exhibitors. Your support will help us achieve our goals in building this robust event while sharing your products with attendees.
Review the Sponsorship Opportunities
Please contact Lissa Martinez Huebner, Senior Event Coordinator, with any questions at mart2948@umn.edu or 612-624-7552.
Thank you to our exhibitors!
- Daiichi-Sankyo
- Eisai
- Teleflex
- Pfizer
- Janssen
- Agios
- Bayer
- Stemline
- BeiGene